Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - colecalciferol, quantity: 25 microgram - capsule, soft - excipient ingredients: d-alpha-tocopherol; purified water; gelatin; vegetable oil; rice bran oil; glycerol - maintain/support general health and wellbeing ; maintain/support bone health ; maintain/support bone strength ; help maintain/support bone mineralisation ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; maintain/support healthy cardiovascular system function ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

ABD - İngilizce - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine tablets, usp is indicated for the treatment of major depressive disorder. the efficacy of venlafaxine tablets, usp in the treatment of major depressive disorder was established in 6 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iii-r category of major depression and in a 4 week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the eff

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

moraf pharmaceuticals limited, tanzania - knee support -

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

moraf pharmaceuticals limited, tanzania - ankle support -

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

moraf pharmaceuticals limited, tanzania - wrist support -

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

moraf pharmaceuticals limited, tanzania - knee support -

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

moraf pharmaceuticals limited, tanzania - stabilizing back support -

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

moraf pharmaceuticals limited, tanzania - hinged knee cap/ hinge knee support -

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

moraf pharmaceuticals limited, tanzania - shoulder support -

ABD - İngilizce - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] •have not provided adequate analgesia, or are not expected to provide adequate analgesia •have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated for: - all children younger than 12 years of age (see warnings ). - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ).  acetaminophen and codeine phosphate tablets are contraindicated in patients wit